Opposition · USPTO

Opposition 91309624

SuspendedUSPTO

Opposition 91309624 at USPTO between LivOn Laboratories, Inc. and TCB USA Corporation, over the mark ELVON, filed Aug 13, 2026. Status in the office record: suspended.

View ELVONGet this data via the API
Status
Suspended
Filed
Aug 13, 2026
Marks involved
8
Parties

Who is involved

The parties as named in the office record.

Opponent

LivOn Laboratories, Inc.

Respondent

TCB USA Corporation

Timeline

How the case has moved

Dates from the USPTO record and the ELVON filing.

  1. ELVON filed

    Application 99753124 filed at the USPTO.

  2. Opposition filed

    LivOn Laboratories, Inc. started opposition 91309624 at USPTO against ELVON.
  3. Next

    Suspended

    No decision is recorded at USPTO yet.
Marks

Marks involved

1 contested mark, 7 marks the challenger relies on.

MarkRoleApplicationOffice
ELVONContested99753124USPTO
LIVON LABSRelied on87675315USPTO
LIVON LABSRelied on87675485USPTO
LIFEONRelied on90297208USPTO
LIVON LABORATORIESRelied on98680488USPTO
LIVON LABORATORIESRelied on98680500USPTO
LIVON LABSRelied on98846947USPTO
LIVON LABSRelied on98846984USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_9e03d27c-5a1a-4a7d-8a6b-3633c6e862bc
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_9e03d27c-5a1a-4a7d-8a6b-3633c6e862bc",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91309624",
  "status": "suspended",
  "office_code": "US",
  "filed_date": "2026-08-13",
  "parties": [
    {
      "name": "LivOn Laboratories, Inc.",
      "role": "opponent"
    },
    {
      "name": "TCB USA Corporation",
      "role": "respondent"
    }
  ]
}